Vuélvete ilimitado con Magzter GOLD

Obtenga acceso ilimitado a más de 9000 revistas, periódicos e historias Premium por solo

$149.99

$74.99/Año

The Perfect Holiday Gift Gift Now

Vuélvete ilimitado con Magzter GOLD

Obtenga acceso ilimitado a más de 9000 revistas, periódicos e historias Premium por solo

$NaN

$NaN/Año

¡Date prisa, oferta por tiempo limitado!

Horas

minutos

artículos de segunda clase

BioSpectrum Asia - August 2022

Vuélvete ilimitado con Magzter GOLD

Leer BioSpectrum Asia junto con más de 9000 revistas y periódicos con una sola suscripción

Ver catálogo

1 mes

$14.99

1 año $149.99

$74.99

$6/month

Save 50%
Hurry, Offer Ends in 13 Days

(OR)

Suscríbete sólo a BioSpectrum Asia

Regalo BioSpectrum Asia

Cancelar en cualquier momento.

(Sin compromisos) ⓘ

Si no estás satisfecho con tu suscripción, puedes enviarnos un correo electrónico a help@magzter.com dentro de los 7 días posteriores a la fecha de inicio de la suscripción para recibir un reembolso completo. ¡Sin preguntas, lo prometemos! (Nota: No se aplica a compras de números individuales)

Suscripción digital

Acceso instantáneo ⓘ

Suscríbete ahora para comenzar a leer instantáneamente en el sitio web de Magzter, iOS, Android y las aplicaciones de Amazon.

Verificado seguro

pago ⓘ

Magzter es un comerciante verificado de Authorize.Net. Más información

En este número

Keeping Pace with MUTATING VIRUSES
A surge in the pandemic has forced the pharma industry to deliver a wide-spectrum vaccine to fight mutation-prone SARS-CoV-2, pledging to prevent future outbreaks. WHO states that the most extensive vaccination campaign in history is providing prophylactic results by delivering more than 12 billion doses of the COVID-19 vaccine, protecting 60 per cent of the global population as of June 2022. Now the next-generation COVID-19 vaccines are countering the
challenge of enhancing the immune response to tackle the emerging COVID-19 variants. It is therefore imperative to remain vigilant and upgrade vaccine candidates to emerging virus sublineages. In order to gain a competitive position in the market, vaccine manufacturers are investing in advanced platform technologies. Let’s take a closer look at some of these leading vaccines approved in APAC as broad spectrum virucide inhibitors.

BioSpectrum Asia Description:

Editor: MM-Activ-Sci-Tech-Communication

Categoría: Business

Idioma: English

Frecuencia: Monthly

BioSpectrum Asia Magazine is a monthly magazine published by MM Activ Sci-Tech Communication in India. It is a leading biotechnology magazine in Asia, covering a wide range of topics related to the biotechnology industry, including:

* Biotechnology news and trends: BioSpectrum Asia covers the latest biotechnology news and trends from India and around the world.

* Biotechnology company profiles and interviews: The magazine profiles leading biotechnology companies in Asia and interviews their CEOs and other top executives.

* Biotechnology research and development: BioSpectrum Asia covers the latest biotechnology research and development from academic institutions and pharmaceutical companies.

* Biotechnology product reviews: The magazine reviews the latest biotechnology products and services.

* Biotechnology industry events: BioSpectrum Asia covers biotechnology industry events from around the world.

BioSpectrum Asia Magazine is a must-read for anyone who wants to stay informed about the latest advances in biotechnology and their potential to impact the world around us.